Latest News of AAIC
AAIC 2024: MCI patient reflects on Leqembi trial experience
By Yahoo! Finance |
3 months ago
Ralph Carmona shared his journey of being diagnosed with Mild Cognitive Impairment (MCI) due to Alzheimer's at the 2024 AAIC session. He participated in a clinical trial for Leqembi, despite recent co...
Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer's Disease at the Alzheimer's Association International Conference® (AAIC)
By Yahoo! Finance |
3 months ago
Longeveron Inc. presents promising Phase 2a clinical trial data on Lomecel-B™ at the AAIC 2024, showing improvements in cognitive function and brain volume in mild Alzheimer's Disease. The therapy d...